PL2631654T3 - Oznaczenie uwalniania neuropeptydu dla kanałów sodowych - Google Patents
Oznaczenie uwalniania neuropeptydu dla kanałów sodowychInfo
- Publication number
- PL2631654T3 PL2631654T3 PL13169122T PL13169122T PL2631654T3 PL 2631654 T3 PL2631654 T3 PL 2631654T3 PL 13169122 T PL13169122 T PL 13169122T PL 13169122 T PL13169122 T PL 13169122T PL 2631654 T3 PL2631654 T3 PL 2631654T3
- Authority
- PL
- Poland
- Prior art keywords
- release assay
- sodium channels
- neuropeptide release
- neuropeptide
- channels
- Prior art date
Links
- 102000003797 Neuropeptides Human genes 0.000 title 1
- 108090000189 Neuropeptides Proteins 0.000 title 1
- 108010052164 Sodium Channels Proteins 0.000 title 1
- 102000018674 Sodium Channels Human genes 0.000 title 1
- 238000003556 assay Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161485488P | 2011-05-12 | 2011-05-12 | |
| US13/155,491 US8871996B2 (en) | 2010-06-09 | 2011-06-08 | Mice expressing human voltage-gated sodium channels |
| US13/236,117 US8486647B2 (en) | 2010-06-09 | 2011-09-19 | Neuropeptide release assay for sodium channels |
| EP12167014.5A EP2527842B1 (en) | 2011-05-12 | 2012-05-07 | Neuropeptide release assay for sodium channels |
| EP13169122.2A EP2631654B1 (en) | 2011-05-12 | 2012-05-07 | Neuropeptide release assay for sodium channels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2631654T3 true PL2631654T3 (pl) | 2015-09-30 |
Family
ID=46045997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13169122T PL2631654T3 (pl) | 2011-05-12 | 2012-05-07 | Oznaczenie uwalniania neuropeptydu dla kanałów sodowych |
Country Status (6)
| Country | Link |
|---|---|
| EP (3) | EP2579039B1 (pl) |
| CY (1) | CY1116625T1 (pl) |
| DK (2) | DK2527842T3 (pl) |
| ES (2) | ES2541535T3 (pl) |
| PL (1) | PL2631654T3 (pl) |
| PT (1) | PT2631654E (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105189553A (zh) | 2013-03-14 | 2015-12-23 | 瑞泽恩制药公司 | Nav1.7的人抗体 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| AU2005295269B2 (en) | 2004-10-19 | 2010-05-13 | Regeneron Pharmaceuticals, Inc. | Method for generating an animal homozygous for a genetic modification |
| US20090298095A1 (en) | 2005-04-15 | 2009-12-03 | The John Hopkins University | Immortalization of cells including neuronal cells |
| WO2007109324A2 (en) * | 2006-03-21 | 2007-09-27 | Xenon Pharmaceuticals, Inc. | Potent and selective nav 1.7 sodium channel blockers |
| ES2398076T3 (es) | 2006-06-02 | 2013-03-13 | Regeneron Pharmaceuticals, Inc. | Anticuerpos de alta afinidad contra el receptor de IL-6 humano |
| EP2262898B1 (en) | 2008-03-07 | 2018-01-24 | Regeneron Pharmaceuticals, Inc. | Es cell-derived mice from diploid host embryo injection |
| CA2751159A1 (en) * | 2009-02-02 | 2010-08-05 | Chromocell Corporation | Cell lines expressing nav and methods of using them |
-
2012
- 2012-05-07 PL PL13169122T patent/PL2631654T3/pl unknown
- 2012-05-07 EP EP12198404.1A patent/EP2579039B1/en active Active
- 2012-05-07 DK DK12167014.5T patent/DK2527842T3/da active
- 2012-05-07 ES ES13169122.2T patent/ES2541535T3/es active Active
- 2012-05-07 PT PT131691222T patent/PT2631654E/pt unknown
- 2012-05-07 DK DK13169122.2T patent/DK2631654T3/en active
- 2012-05-07 ES ES12198404.1T patent/ES2656852T3/es active Active
- 2012-05-07 EP EP13169122.2A patent/EP2631654B1/en active Active
- 2012-05-07 EP EP12167014.5A patent/EP2527842B1/en active Active
-
2015
- 2015-07-07 CY CY20151100591T patent/CY1116625T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2527842A1 (en) | 2012-11-28 |
| ES2656852T3 (es) | 2018-02-28 |
| EP2527842B1 (en) | 2013-06-05 |
| EP2631654B1 (en) | 2015-04-15 |
| HK1185943A1 (en) | 2014-02-28 |
| PT2631654E (pt) | 2015-08-21 |
| DK2631654T3 (en) | 2015-07-20 |
| ES2541535T3 (es) | 2015-07-21 |
| EP2631654A1 (en) | 2013-08-28 |
| DK2527842T3 (da) | 2013-09-08 |
| CY1116625T1 (el) | 2017-03-15 |
| HK1174387A1 (en) | 2013-06-07 |
| EP2579039A1 (en) | 2013-04-10 |
| EP2579039B1 (en) | 2017-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286152A (en) | Modified imidazopyridinyl-aminopyridine compounds | |
| GB201108678D0 (en) | Multiplexed proximity ligation assay | |
| GB201106395D0 (en) | Compounds | |
| GB201109763D0 (en) | Compounds | |
| PL2572204T3 (pl) | Odczynnik do uwalniania dla związków witaminy d | |
| DK2783152T3 (da) | Trykafgivelsessystem | |
| IL228609A0 (en) | Sustained release silver compound for water purification | |
| GB201107197D0 (en) | Compounds | |
| SG11201402196YA (en) | Release reagent for vitamin d compounds | |
| PL2766541T3 (pl) | Człon łączący do rusztowań | |
| PL2729809T3 (pl) | Test oznaczający | |
| EP2687374A4 (en) | INTERFACE | |
| GB201110938D0 (en) | Compounds | |
| GB201106615D0 (en) | Assay | |
| GB201105659D0 (en) | Compounds | |
| GB201102659D0 (en) | Assay | |
| PL2631654T3 (pl) | Oznaczenie uwalniania neuropeptydu dla kanałów sodowych | |
| GB201121265D0 (en) | Assay | |
| GB201113101D0 (en) | Assay | |
| GB201118613D0 (en) | Compounds | |
| HUP1100207A2 (en) | Modified release composition | |
| GB201102162D0 (en) | Contraceptive compounds | |
| GB201107431D0 (en) | Assay | |
| GB201117309D0 (en) | Assay | |
| GB201111698D0 (en) | Assay |